尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Friberg Gregory R. Insider active across 1 company, notably Biomarin Pharmaceutical INC. In total, 6 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €323k. Activity tracked since 30 September 2024. The latest transaction was disclosed on 16 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Friberg Gregory R is a declarant linked to Biomarin Pharmaceutical INC. Across 6 filings on record, the 6 sampled filings run from 2024-10-01 to 2026-03-18, with EUR 323260 of sales and EUR 0 of purchases. No primary role is provided, although the company listed him as EVP, Chief R&D Officer.